Insiders · Profile

Chapman Marcus

See Remarks at Seres Therapeutics. Filing since 22 Nov 2019. CIK 0001770404

Company

Date

Role

Action

Shares

Amount

Of holding

MCRB Seres Therapeutics, Inc.

22 Nov 2019

See Remarks

Sold, plan not stated

3,400

$13.30K

28.3%

1 decision on file.